ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,869.20
      0.39%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      84.315
      -0.33%
      Bitcoin
      63,718.55
      4.83%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. AbbVie Inc (ABBV)

      7. AbbVie Inc (ABBV) News

      ABBV

      AbbVie (ABBV)

      AbbVie Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:ABBV
      DateTimeSourceHeadlineSymbolCompany
      04/15/202011:10AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/14/202010:12AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/14/20209:56AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/09/202010:15AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/08/202010:57AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/07/20209:45AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/07/20209:09AMEdgar (US Regulatory)Notice of Exempt Solicitation. Definitive Material. (px14a6g)NYSE:ABBVAbbVie Inc
      04/06/202011:50AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/06/20208:09AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      04/06/20208:00AMPR Newswire (US)AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan NotesNYSE:ABBVAbbVie Inc
      04/03/202010:37AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      04/02/20205:04PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      04/02/20205:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      04/02/20205:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      04/02/20205:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:ABBVAbbVie Inc
      04/02/20208:00AMPR Newswire (US)AbbVie to Host First-Quarter 2020 Earnings Conference CallNYSE:ABBVAbbVie Inc
      04/01/202011:17AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/31/20207:24PMPR Newswire (US)AbbVie Donates $35 Million for COVID-19 Relief to Support Healthcare Systems, Patients and CommunitiesNYSE:ABBVAbbVie Inc
      03/27/202010:48AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/26/202012:10PMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/26/20206:07AMEdgar (US Regulatory)Notice of Exempt Solicitation. Definitive Material. (px14a6g)NYSE:ABBVAbbVie Inc
      03/25/202011:19AMDow Jones NewsForm 8.3 - Allergan PlcNYSE:ABBVAbbVie Inc
      03/24/20209:58AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/24/20206:01AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:ABBVAbbVie Inc
      03/23/20205:23PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:ABBVAbbVie Inc
      03/23/202010:59AMDow Jones NewsForm 8.3 - [Allergan Plc]NYSE:ABBVAbbVie Inc
      03/23/20209:28AMDow Jones NewsAbbVie Says Acute Myeloid Leukemia Trial Meets EndpointsNYSE:ABBVAbbVie Inc
      03/23/20208:14AMEdgar (US Regulatory)Current Report Filing (8-k)NYSE:ABBVAbbVie Inc
      03/23/20208:00AMPR Newswire (US)AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan NotesNYSE:ABBVAbbVie Inc
      03/23/20208:00AMPR Newswire (US)AbbVie Announces Positive Topline Results from Phase 3 Trial of VENCLEXTA® (venetoclax) in Combination with Azacitidine in P...NYSE:ABBVAbbVie Inc
       Showing the most relevant articles for your search:NYSE:ABBV